Differentiation and subsequent development of the gut represents an important clinical topic but one that is, to date, poorly understood. Sets of genes are turned on or off in an ordered and synchronized pattern as the intestine evolves from an undifferentiated endoderm into its adult differentiated form; these changes in gene expression are mediated primarily by the activation or repression of gene transcription. Our previous findings have identified the terminally- differentiated neurotensin (NT) gene (designated NT/N) as an excellent molecular model to delineate the complex cellular mechanisms regulating the region-specific patterns of expression which lead to differentiation and specialized function. We have shown that NT/N expression is developmentally regulated in a distinctive temporal- and spatial- specific pattern; NT/N expression is initially low in the fetus but rapidly increases after birth to assume the distinctive adult topographical distribution with increasing NT/N expression along the longitudinal axis of the small bowel. In the human colon, NT/N is transiently expressed in the fetus but is repressed in the adult; however, NT/N is reexpressed in certain colon cancers. The central hypothesis of our proposal continues to be that the strict expression pattern of NT/N in the gut is regulated by mechanisms which involve mainly transcriptional regulation. To examine this hypothesis we have panned experiments with the following SPECIFIC AIMS: (l) We will further define the factors regulating the developmental pattern of NT/N expression in the gut. (2) We will determine the mechanisms leading to ectopic NT/N expression in colon cancers. (3) We will characterize the age-related alterations of NT/N expression and NT-mediated growth in the gut. (4) We will analyze in vivo the NT/N regulatory elements required for the strict expression pattern in the gut. To achieve this goal, we will develop transgenic lines with the human NT/N regulatory region linked to a reporter gene to determine the elements that are required to recapitulate the normal developmental pattern of NT/N expression. The ultimate goal of our studies is to define the molecular mechanisms regulating NT/N expression in vivo. Understanding the protein-DNA interactions that are required for restricting NT/N expression will yield important information on the regulation and attainment of the differentiated gut phenotype. In addition, analysis of these cellular processes will provide a better understanding of not only normal gut development and function but may also provide a model to better elucidate the cellular events leading to gut neoplasia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG010885-06
Application #
2001449
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Bellino, Francis
Project Start
1992-08-01
Project End
2002-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
6
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Surgery
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Kim, Sunghoon; Kang, Junghee; Evers, B Mark et al. (2004) Interferon-gamma induces caspase-8 in neuroblastomas without affecting methylation of caspase-8 promoter. J Pediatr Surg 39:509-15
Kim, Sunghoon; Kang, Junghee; Hu, Wanqin et al. (2003) Geldanamycin decreases Raf-1 and Akt levels and induces apoptosis in neuroblastomas. Int J Cancer 103:352-9
Evers, B Mark (2002) Endocrine gene neurotensin: molecular mechanisms and a model of intestinal differentiation. World J Surg 26:799-805
Thomas, Robert P; Guigneaux, Michelle; Wood, Thomas et al. (2002) Age-associated changes in gene expression patterns in the liver. J Gastrointest Surg 6:445-53; discussion 454
Wang, Qingding; Li, Nan; Wang, Xiaofu et al. (2002) Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3'-kinase inhibition in the KM20 human colon cancer cell line. Clin Cancer Res 8:1940-7
Thomas, Robert P; Farrow, Buckminster J; Kim, Sunghoon et al. (2002) Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Surgery 132:127-34
Wang, Q; Wang, X; Hernandez, A et al. (2001) Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation. Gastroenterology 120:1381-92
Hernandez, A; Wang, Q D; Schwartz, S A et al. (2001) Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg 5:56-65
Hernandez, A; Thomas, R; Smith, F et al. (2001) Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 130:265-72
Dong, Z; Wang, X; Evers, B M (2000) Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers. Am J Physiol Gastrointest Liver Physiol 279:G1139-47

Showing the most recent 10 out of 26 publications